☆ 4.8 Editorial Material

Low-Grade Inflammation Modifies Cardiovascular Risk Even at Very Low LDL-C Levels: Are We Aiming for a Dual Target Concept?

CIRCULATION (2018)

Get Full Text
Add to Collection

Journal

CIRCULATION
Volume 138, Issue 2, Pages 150-153

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/CIRCULATIONAHA.118.035107

Keywords

Editorials; C-reactive protein; inflammation; lipoproteins; LDL; myocardial infarction; risk factors

Categories

Cardiac & Cardiovascular Systems Peripheral Vascular Disease

Funding

  1. Novartis
  2. Pfizer
  3. DalCor
  4. Sanofi
  5. Kowa
  6. Amgen
  7. AstraZeneca

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.